Immune Therapies Showing Promise on Coronavirus: Johns Hopkins

Apr.06 — Returning to public will be like a “dimmer switch” until the light can be fully turned on, says John Hopkins Vice Dean for Public Health Practice Josh Sharfstein. He addresses the approval process for treatments and where success has been seen in combatting coronavirus on “Bloomberg Surveillance.” The Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder and majority owner of Bloomberg LP, the parent company of Bloomberg News.